Biologic therapies in the metastatic colorectal cancer treatment continuum--applying current evidence to clinical practice.

Abstract excerpt

More therapeutic options are now available than ever before for patients with metastatic colorectal cancer (mCRC) and, as such, treatment decisions have become more complex. A multidisciplinary approach is, therefore, required to effectively manage these patients. In the past few years, many trials have reported on the value of combining biological agents, such as those targeting vascular endothelial growth...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Bevacizumab
• Share to Capecitabine
• Share to Deoxycytidine